AAAAAA
Results:
1-18
|
Results: 18
Authors:
CATTRAN D
Citation: D. Cattran, PREDICTING OUTCOME IN THE IDIOPATHIC GLOMERULOPATHIES, JN. Journal of nephrology, 11(2), 1998, pp. 57-60
Authors:
WILMER WA
HEBERT LA
LEWIS EJ
WHITTIER F
CATTRAN D
LEVEY A
BREYER J
SPITALEWITZ S
BLUMENTHAL S
Citation: Wa. Wilmer et al., LONG-TERM FOLLOW-UP OF THE 8 PATIENTS WITH DIABETIC NEPHROPATHY WHO EXPERIENCED REMISSION OF NEPHROTIC SYNDROME DURING THE CAPTOPRIL STUDY, Journal of the American Society of Nephrology, 8, 1997, pp. 573-573
Authors:
ZENT R
KATZ A
QUAGGIN S
CATTRAN D
WADE J
CARDELLA C
ZALTZMAN J
FENTON S
COLE E
Citation: R. Zent et al., THROMBOTIC MICROANGIOPATHY IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE-A, Clinical nephrology, 47(3), 1997, pp. 181-186
Authors:
CARDELLA CJ
CATTRAN D
FENTON SA
ALBERT S
ROBINETTE M
COLE E
Citation: Cj. Cardella et al., INDUCTION THERAPY WITH RABBIT ANTITHYMOCYTE SERA REDUCES REJECTION EPISODES IN IMMUNOLOGICALLY LOW-RISK LIVING DONOR RENAL-TRANSPLANT RECIPIENTS, Transplantation proceedings, 29(7A), 1997, pp. 29-31
Authors:
CHAN C
MAURER J
CARDELLA C
CATTRAN D
PEI Y
Citation: C. Chan et al., A RANDOMIZED CONTROLLED TRIPLE OF VERAPAMIL ON CYCLOSPORINE NEPHROTOXICITY IN HEART AND LUNG-TRANSPLANT RECIPIENTS, Transplantation, 63(10), 1997, pp. 1435-1440
Authors:
PEI Y
SCHOLEY J
THAI K
SUZUKI M
CATTRAN D
Citation: Y. Pei et al., ASSOCIATION OF ANGIOTENSINOGEN GENE T235 VARIANT WITH PROGRESSION OF IMMUNOGLOBIN-A NEPHROPATHY IN CAUCASIAN PATIENTS, The Journal of clinical investigation, 100(4), 1997, pp. 814-820
Authors:
CATTRAN D
LALUCK B
Citation: D. Cattran et B. Laluck, LONG-TERM OUTCOME AFTER COMPLETE REMISSION (CR) IN IDIOPATHIC MEMBRANOUS NEPHROPATHY (IMGN), Journal of the American Society of Nephrology, 7(9), 1996, pp. 688-688
Authors:
CATTRAN D
RAO P
Citation: D. Cattran et P. Rao, LONG-TERM OUTCOME IN FOCAL SEGMENTAL GLOMERULONEPHRITIS (FSGN) IN CHILDREN (C) VERSUS ADULTS (A), Journal of the American Society of Nephrology, 7(9), 1996, pp. 689-689
Authors:
BREYER JA
BAIN RP
EVANS JK
NAHMAN NS
LEWIS EJ
COOPER M
MCGILL J
BERL T
ROHDE R
HUNSICKER LG
LACHIN J
GREENHOUSE SW
VERME DA
TURLINGTON TR
BURROWS PK
WISH J
SHEEHAN J
POHL M
BERL T
SANTIAGO G
HUNSICKER L
KERN EFO
LEMANN J
BLEMENTHAL S
BRESNAHAN BS
HEBERT L
GOLDFARB S
KOBRIN S
RODBY R
LEVEY A
MCLAUGHLIN M
WILLIAMS M
MCGILL J
WHITTLER F
RUTECKI G
CATTRAN D
LIETZ S
VALAITIS D
HANO J
MAXWELL D
PORUSH J
SPITALEWITZ S
SHAPIRO K
ADLER S
TOLCHIN N
HOY W
BERNSTEIN R
SVETKEY L
SHARON Z
RAUSENBAUM B
ANOLIK JR
TILDESLEY H
JOYCE C
FARID N
BREYER J
SCHULMAN G
Citation: Ja. Breyer et al., PREDICTORS OF THE PROGRESSION OF RENAL-INSUFFICIENCY IN PATIENTS WITHINSULIN-DEPENDENT DIABETES AND OVERT DIABETIC NEPHROPATHY, Kidney international, 50(5), 1996, pp. 1651-1658
Authors:
CATTRAN D
GREENWOOD C
HERBERT L
POHL M
HUNSICKER L
MAXWELL D
KUNIS C
Citation: D. Cattran et al., FOLLOW-UP RESULTS FROM A RANDOMIZED CONTROLLED TRIAL (RCT) OF CYCLOSPORINE (T) VS PLACEBO (C) IN ADULTS WITH STEROID-RESISTANT IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS (SR-FSGS), Journal of the American Society of Nephrology, 6(3), 1995, pp. 414-414
Authors:
CATTRAN D
GREENWOOD C
BERNSTEIN K
HEBERT L
POHL M
MAXWELL D
APPEL G
HOY W
FABER M
HEGEMAN R
Citation: D. Cattran et al., RESULTS OF A 6 MONTH RANDOMIZED CONTROLLED TRIAL OF CYCLOSPORINE (T) VS PLACEBO (C) IN ADULTS WITH STEROID-RESISTANT IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS (SR-FSGS), Journal of the American Society of Nephrology, 6(3), 1995, pp. 415-415
Authors:
PEI Y
SCHOLEY JW
THAI K
KUA BT
CHAN W
IBELS L
CATTRAN D
Citation: Y. Pei et al., GENETIC-POLYMORPHISM OF RENIN-ANGIOTENSIN SYSTEM IN PROGRESSIVE IGA NEPHROPATHY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 430-430
Authors:
RODBY RA
ROHDE R
EVANS J
BAIN RP
MULCAHY WS
LEWIS EJ
SHEEHAN J
POHL M
BERT T
LEMANN J
BLUMENTHAL S
BRESNAHAN BS
HEBERT L
NAHMAN NS
RODBY R
MCGILL J
WHITTIER F
CATTRAN D
MAXWELL D
PORUSH J
SPITALEWITZ S
SHAPIRO K
ADLER S
TOLCHIN N
SVETKEY L
SHARON Z
RAUSENBAUM B
BREYER J
Citation: Ra. Rodby et al., THE STUDY OF THE EFFECT OF INTENSITY OF BLOOD-PRESSURE MANAGEMENT ON THE PROGRESSION OF TYPE-1 DIABETIC NEPHROPATHY - STUDY DESIGN AND BASE-LINE PATIENT CHARACTERISTICS, Journal of the American Society of Nephrology, 5(10), 1995, pp. 1775-1781
Authors:
COLE E
NAIMARK D
APRILE M
WADE J
CATTRAN D
PEI Y
FENTON S
ROBINETTE M
ZALTSMAN J
BEAR R
CARDELLA C
Citation: E. Cole et al., AN ANALYSIS OF PREDICTORS OF LONG-TERM CADAVERIC RENAL-ALLOGRAFT SURVIVAL, Clinical transplantation, 9(4), 1995, pp. 282-288
Authors:
PEI Y
CHAN C
CATTRAN D
CARDELLA C
ZALTZMAN J
LOPEZ M
TONG J
SCHACHTER R
MAURER J
Citation: Y. Pei et al., SUSTAINED VASOCONSTRICTION ASSOCIATED WITH DAILY CYCLOSPORINE DOSE INHEART AND LUNG-TRANSPLANT RECIPIENTS - POTENTIAL PATHOPHYSIOLOGIC ROLE OF ENDOTHELIN, The Journal of laboratory and clinical medicine, 125(1), 1995, pp. 113-119
Authors:
PEI Y
SCHOLEY JW
KATZ A
SCHACHTER R
MURPHY GF
CATTRAN D
Citation: Y. Pei et al., CHRONIC NEPHROTOXICITY IN PSORIATIC PATIENTS TREATED WITH LOW-DOSE CYCLOSPORINE, American journal of kidney diseases, 23(4), 1994, pp. 528-536
Authors:
HEBERT LA
BAIN RP
VERME D
CATTRAN D
WHITTIER FC
TOLCHIN N
ROHDE RD
LEWIS EJ
Citation: La. Hebert et al., REMISSION OF NEPHROTIC RANGE PROTEINURIA IN TYPE-I DIABETES, Kidney international, 46(6), 1994, pp. 1688-1693
Authors:
SPITALEWITZ S
PORUSH JG
CATTRAN D
WRIGHT N
Citation: S. Spitalewitz et al., TREATMENT OF HYPERLIPIDEMIA IN THE NEPHROTIC SYNDROME - THE EFFECTS OF PRAVASTATIN THERAPY, American journal of kidney diseases, 22(1), 1993, pp. 143-150
Risultati:
1-18
|